Search results for: France
Filter search results
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…negative economic and social consequences – a GDP decrease of 20%-30% for the G7 – with associated mortality and morbidity. When countries (i.e. Spain, Italy, UK, France) see lockdowns have…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
…and France. The US spends more on health care than any other developed country – 17.1% of US GDP ($3.8 trillion) in 2019 and double the per capita spend in…
Ophthalmic Service
1 July 1970
…France and Germany. There the optician has remained much more closely associated with the manufacture of spectacles. This paper is concerned with only one specialised part of eye care, that…
How Have HTA Agencies Evolved Their Methods Over Time?
29 April 2024
Share this: Download publication Priscila Radu Gayathri Kumar Patricia Cubi-Molla Martina Garau Eleanor Bell Jia Pan Ramiro Gilardino Julie Van Bavel Agnes Brandtmüller Katherine Nelson Melinda Goodall The many changes…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
1 September 2019
Antimicrobial resistance (AMR) is a growing public health threat, limiting the ability of health care systems to prevent and treat infections and save lives. In parallel, global antibiotic development pipelines…
Indication-Based Pricing (IBP) Consultation Report
1 April 2020
Although the science underlying drug development has evolved, there has been little change in how we pay for them. As more and more medicines come to market with multiple indications…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies
8 January 2020
Histology independent therapies, a new class of medicines that target cancer based on specific genomic or molecular alterations of cancer cells rather than tissue of origin, face significant methodological and…